longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

300534

300534
----

LongbridgeAI

Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Manufacturing License"

Zhitong
Sep 25, 2025 at 08:36 AM

Longshenrongfa Pharmaceutical Industry announced that its holding subsidiary, Gansu Puan Pharmaceutical Co., Ltd., has completed the renewal procedures for the "Drug Manufacturing License" due to the application for the reduction of entrusted production related matters. On September 25, 2025, it received the renewed "Drug Manufacturing License" approved by the Gansu Provincial Drug Administration. The change in this "Drug Manufacturing License" is mainly due to Puan Pharmaceutical's application for the reduction of the entrusted production of the Xuanfei Zhike Decoction and has completed the change procedures in accordance with the law, which will not have a significant impact on production and operations

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Longshenrongfa Pharmaceutical Industry

Longshenrongfa Pharmaceutical Industry

300534.SZ

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--